Results 21 to 30 of about 687,738 (249)

Ethical considerations in an era of mass drug administration [PDF]

Parasites & Vectors, 2013
In a Plenary debate at the 51st Spring meeting of the British Society of Parasitology, Bristol, UK, April 8-11, 2013, the bioethicist James Wilson used the value of a life in the present and future to question the effectiveness of current health strategies.
Wharam, Barney, Lazarou, Luke
openaire   +4 more sources

Modelling strategies to break transmission of lymphatic filariasis - aggregation, adherence and vector competence greatly alter elimination

Parasites & Vectors, 2015
Background With ambitious targets to eliminate lymphatic filariasis over the coming years, there is a need to identify optimal strategies to achieve them in areas with different baseline prevalence and stages of control.
M. A. Irvine, L. J. Reimer, S. M. Njenga, S. Gunawardena, L. Kelly-Hope, M. Bockarie, T. D. Hollingsworth   +6 more
doaj   +1 more source

Directly observed treatment increases drug compliance in lymphatic filariasis mass drug administration

Universa Medicina, 2016
Backgroud. Mass drug administration (MDA) has been one of the strategies for lymphatic filariasis elimination. Since the start of implementation in 2011 in Pekalongan, no study on MDA acceptability has yet been done.
Tutik Ida Rosanti, Sugeng Juwono Mardihusodo, Wayan T. Artama   +2 more
doaj   +1 more source

Human schistosomiasis in the post mass drug administration era [PDF]

The Lancet Infectious Diseases, 2017
Profound changes are occurring in the epidemiology of schistosomiasis, a neglected tropical disease caused by a chronic infection with parasitic helminths of the genus Schistosoma. Schistosomiasis currently affects 240 million people worldwide, mostly in sub-Saharan Africa. The advent and proliferation of mass drug administration (MDA) programmes using
Mutapi, Francisca, Maizels, Rick, Fenwick, Alan, Woolhouse, Mark; id_orcid 0000-0003-3765-8167   +3 more
openaire   +3 more sources

Stopping azithromycin mass drug administration for trachoma: A systematic review.

PLoS Neglected Tropical Diseases, 2021
The World Health Organization (WHO) recommends continuing azithromycin mass drug administration (MDA) for trachoma until endemic regions drop below 5% prevalence of active trachoma in children aged 1-9 years.
Hamidah Mahmud, Emma Landskroner, Abdou Amza, Solomon Aragie, William W Godwin, Anna de Hostos Barth, Kieran S O'Brien, Thomas M Lietman, Catherine E Oldenburg   +8 more
doaj   +1 more source

Emerging antihelminthic drug resistance: Implications for mass drug administration program

One Health Bulletin
Soil transmitted helminth infections and lymphatic diseases are significant neglected tropical diseases that pose public health challenges in both low and middle economic populations.
Agarwal Harshita, Rajkumari Nonika
doaj   +1 more source

Feasibility and safety of mass drug coadministration with azithromycin and ivermectin for the control of neglected tropical diseases: a single-arm intervention trial

The Lancet Global Health, 2018
Summary: Background: Mass drug administration has made a major contribution to the public health control of several important neglected tropical diseases.
Lucia Romani, PhD, Michael Marks, PhD, Oliver Sokana, MPH, Titus Nasi, MCH, Bakaai Kamoriki, Handan Wand, PhD, Margot J Whitfeld, FACD, Daniel Engelman, FRACP, Anthony W Solomon, FRCP, Andrew C Steer, ProfPhD, John M Kaldor, ProfPhD   +10 more
doaj   +1 more source

Mass Drug Administration of Triclabendazole for Fasciola Hepatica in Bolivia [PDF]

The American Journal of Tropical Medicine and Hygiene, 2019
Human infection with Fasciola hepatica leads to obstruction of the common bile duct by adult worms and disease characterized by biliary colic, epigastric pain, and nausea. Recommended treatment is a single dose of triclabendazole (TCBZ) (10 mg/kg).
Sergio, Mollinedo, Patricia, Gutierrez, Rosa, Azurduy, Freddy, Valle, Alejandra, Salas, Zoraida, Mollinedo, Paula, Soto, Cleye F, Villarroel, Janet, Ransom, Robb, Lawrence, Jonathan, Berman, Jaime, Soto   +11 more
openaire   +2 more sources

Awareness of and participation in mass drug administration programs used for onchocerciasis control in the Atwima Nwabiagya North District, Ghana

Global Health Research and Policy, 2023
Background Studies on Mass drug administration (MDA) in Ghana targeting various diseases, have mostly focused on factors that affect coverage and compliance to MDA with limited focus on evidence regarding awareness and community perception of the program.
Francis Adjei Osei, Sam Kofi Tekyi Newton, Isaac Nyanor, Eugene Osei-Yeboah, Evans Xorse Amuzu, Nicholas Karikari Mensah, Obed Ofori Nyarko, Ernest Amanor, Samuel Frimpong Odoom, Suraj Yawnumah Abubakar, Mathias Dongyele, Aliyu Mohammed, Ofeibea Asare, Stephanie Boadi, Peter Furu, Dan Wolf Meyrowitsch, Ellis Owusu-Dabo   +16 more
doaj   +1 more source

Persistence of onchocerciasis in villages in Enugu and Ogun states in Nigeria following many rounds of mass distribution of ivermectin

BMC Infectious Diseases, 2022
Background Onchocerciasis is endemic in most local government areas (LGAs) in Enugu and Ogun states. Most meso- and hyper-endemic LGAs have received many rounds of ivermectin mass drug administration (MDA).
Uwem F. Ekpo, Obiora A. Eneanya, Edith N. Nwankwo, Islamiat Y. Soneye, Gary J. Weil, Peter U. Fischer, Obioma C. Nwaorgu   +6 more
doaj   +1 more source